BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38002699)

  • 1. Follow-Up of Men Who Have Undergone Focal Therapy for Prostate Cancer with HIFU-A Real-World Experience.
    Mala KS; Plage H; Mödl L; Hofbauer S; Friedersdorff F; Schostak M; Miller K; Schlomm T; Cash H
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of post-ablation mpMRI as a predictor of residual prostate cancer after focal high intensity focused ultrasound (HIFU) ablation.
    Khandwala YS; Morisetty S; Ghanouni P; Fan RE; Soerensen SJC; Rusu M; Sonn GA
    Urol Oncol; 2022 Nov; 40(11):489.e9-489.e17. PubMed ID: 36058811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-term Oncological Efficacy and Patient-reported Outcomes After Focal High-intensity Focused Ultrasound: The FOXPRO Trial.
    Westhoff N; Ernst R; Kowalewski KF; Derigs F; Neuberger M; Nörenberg D; Popovic ZV; Ritter M; Stephan Michel M; von Hardenberg J
    Eur Urol Focus; 2023 Mar; 9(2):283-290. PubMed ID: 36344395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.
    Guillaumier S; Peters M; Arya M; Afzal N; Charman S; Dudderidge T; Hosking-Jervis F; Hindley RG; Lewi H; McCartan N; Moore CM; Nigam R; Ogden C; Persad R; Shah K; van der Meulen J; Virdi J; Winkler M; Emberton M; Ahmed HU
    Eur Urol; 2018 Oct; 74(4):422-429. PubMed ID: 29960750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
    Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
    Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [FOCAL THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND FOR THE LOCALIZED PROSTATE CANCER BASED ON THE LOCALIZATION WITH MRI-TRUS FUSION IMAGE-GUIDED BIOPSY: 1-YEAR PROSPECTIVE STUDY].
    Shoji S; Hiraiwa S; Ogawa T; Hanada I; Nakano M; Zakoji H; Hashida K; Matsumoto T; Hasebe T; Tajiri T; Uchida T; Miyajima A
    Nihon Hinyokika Gakkai Zasshi; 2018; 109(4):194-203. PubMed ID: 31631082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
    von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
    Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Systematic Control Biopsies following Partial Gland Ablation with High-Intensity Focused Ultrasound for Clinically Significant Prostate Cancer.
    Rompré-Brodeur A; Marcq G; Tholomier C; Fugaru I; Loutochin O; Anidjar M; Bladou F
    J Urol; 2021 Nov; 206(5):1177-1183. PubMed ID: 34251879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected.
    Duwe G; Boehm K; Haack M; Sparwasser P; Brandt MP; Mager R; Tsaur I; Haferkamp A; Höfner T
    World J Urol; 2023 May; 41(5):1293-1299. PubMed ID: 36920492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological Outcome and Value of Postoperative Magnetic Resonance Imaging after Focal High-Intensity Focused Ultrasound Therapy for Prostate Cancer.
    Rosenhammer B; Niessen C; Rotzinger L; Reiss J; Schnabel MJ; Burger M; Bründl J
    Urol Int; 2019; 103(3):270-278. PubMed ID: 31466073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HIFU therapy of localized prostate cancer using image-guided robotic HIFU Focal One].
    Govorov AV; Vasilyev AO; Alaverdyan AI; Kolontarev KB; Pushkar DY
    Urologiia; 2023 May; (2):83-89. PubMed ID: 37401710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Exploratory Study of Dose Escalation
    Huber PM; Afzal N; Arya M; Boxler S; Dudderidge T; Emberton M; Guillaumier S; Hindley RG; Hosking-Jervis F; Leemann L; Lewi H; McCartan N; Moore CM; Nigam R; Odgen C; Persad R; Thalmann GN; Virdi J; Winkler M; Ahmed HU
    J Endourol; 2020 Jun; 34(6):641-646. PubMed ID: 32253928
    [No Abstract]   [Full Text] [Related]  

  • 13. Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?
    Rakauskas A; Shah TT; Peters M; Randeva JS; Hosking-Jervis F; Schmainda MJ; Orczyck C; Emberton M; Arya M; Moore C; Ahmed HU
    Urol Oncol; 2021 Dec; 39(12):830.e1-830.e8. PubMed ID: 34049783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer.
    Kanthabalan A; Peters M; Van Vulpen M; McCartan N; Hindley RG; Emara A; Moore CM; Arya M; Emberton M; Ahmed HU
    BJU Int; 2017 Aug; 120(2):246-256. PubMed ID: 28258616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes.
    Feijoo ER; Sivaraman A; Barret E; Sanchez-Salas R; Galiano M; Rozet F; Prapotnich D; Cathala N; Mombet A; Cathelineau X
    Eur Urol; 2016 Feb; 69(2):214-20. PubMed ID: 26164416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does mpMRI guidance improve HIFU partial gland ablation compared to conventional ultrasound guidance? Early functional outcomes and complications from a single center.
    Sivaraman A; Marra G; Stabile A; Mombet A; Macek P; Lanz C; Cathala N; Moschini M; Carneiro A; Sanchez-Salas R; Cathelineau X
    Int Braz J Urol; 2020; 46(6):984-992. PubMed ID: 32822127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIFU focal therapy for prostate cancer using intraoperatory contrast enhanced ultrasound.
    Claros OR; Tourinho-Barbosa RR; Carneiro A; Collura-Merlier S; Macek P; Lanz C; Cathala N; Prapotnich D; Mombet A; Sanchez-Salas R; Cathelineau X
    Arch Esp Urol; 2019 Oct; 72(8):825-830. PubMed ID: 31579041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer.
    Bacchetta F; Martins M; Regusci S; Jichlinski P; Meuwly JY; Lucca I; Valerio M
    Urol Oncol; 2020 Nov; 38(11):846.e1-846.e7. PubMed ID: 32532530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal therapy with high-intensity focused ultrasound for the localized prostate cancer for Asian based on the localization with MRI-TRUS fusion image-guided transperineal biopsy and 12-cores transperineal systematic biopsy: prospective analysis of oncological and functional outcomes.
    Shoji S; Hiraiwa S; Uemura K; Nitta M; Hasegawa M; Kawamura Y; Hashida K; Hasebe T; Tajiri T; Miyajima A
    Int J Clin Oncol; 2020 Oct; 25(10):1844-1853. PubMed ID: 32556840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Intensity Focused Ultrasound (HIFU) Focal Therapy for Localized Prostate Cancer with MRI-US Fusion Platform.
    Yee CH; Chiu PK; Teoh JY; Ng CF; Chan CK; Hou SM
    Adv Urol; 2021; 2021():7157973. PubMed ID: 34950204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.